Добавил:
Sekretar
kiopkiopkiop18@yandex.ru
t.me/Prokururor I Вовсе не секретарь, но почту проверяю
Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз:
Предмет:
Файл:Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_5918_Библиотеки_им_академика_М_И_Перельмана
.pdf
12 Immunoinformatics fortheDiagnosis andMonitoring ofAutoimmune Diseases
https://t.me/med1917
249
diseases, including systemic lupus erythematosus (SLE) and rheumatoid arthritis
(Anaya et al. 2016). Studies have identied various human leukocyte antigens
(HLA) and various non-HLA genes associated with various autoimmune diseases
(Vojdani 2014).
However, autoimmunity cannot be triggered solely by the presence of these
genetic markers, highlighting the signicance of environmental variables. The onset
and development of autoimmune reactions have been linked to environmental variables, including infections, hormone uctuations, and exposure to specic chemicals. For example, molecular mimicry (Fig. 12.1), the process by which viral
antigens resemble self-antigens and trigger cross-reactive immune responses, has
been used to link viral infections to the onset of type 1 diabetes (Fujinami and
Oldstone 1989). Moreover, changes in the makeup of the gut microbiota have been
associated with the development of various autoimmune diseases, highlighting the
importance of the gut-immune axis in preserving immunological homeostasis (Wu
and Wu 2012).
Regulatory T cells (Tregs), a subset of T cells, are crucial in controlling the
immune system and keeping it from attacking its own tissues of the body (Sakaguchi
etal. 2008). In addition to being generated from naive T cells in the periphery, the
thymus, a gland in the chest, also plays a role in Treg production (Sakaguchi etal.
2008; Baecher-Allan 2004).
The ability to remain tolerant and reject self-antigens requires Tregs. Tregs are
necessary to prevent the immune system from attacking the body’s own tissues,
Fig. 12.1 Illustration of molecular mimicry
250
https://t.me/med1917
S. Gangwar et al.
which can result in autoimmune illnesses like rheumatoid arthritis (Hirota et al.
2007), multiple sclerosis, and type 1 diabetes (Szanya etal. 2002). Additionally,
Tregs are involved in the suppression of hyperactive immunological reactions to
external antigens, including those triggered by infections or allergic reactions
(Belkaid etal. 2002). Tissue damage might result from the immune system overreacting and not having Tregs. Immune tolerance maintenance and the prevention of
autoimmune disorders depend on regulatory T cells or Tregs. Additionally, they aid
in reducing overreactions of the immune system to foreign antigens. Numerous
inammatory and immunological disorders can result from Treg imbalance
(Sakaguchi etal. 2008).
Also, in case of infections like tuberculosis and cold sores brought on by herpesviruses, the immune response does not always result in the total clearance of infections. In vulnerable people, these infections can colonize for an extended period of
time. In these circumstances, studies of antigen-specic immune cells show signicant distinctions between both naive and effector cells. There are two main ways in
which aggressive immune responses are suppressed in these situations. First, cells
that are actively combating the infection display an intrinsic shutdown mechanism,
which is identied by a rise in the surface expression of co-inhibitory receptors
(Table12.1). These receptors send out signals that stop attacking processes like cell
death, which stops local tissue damage and elimination of pathogen-infected cells.
This balance allows for the tolerance of infected cells while minimizing further harm.
The second type of regulation occurs extrinsically through the expansion of
antigen- specic anti-inammatory cytokines released by these cells to limit immunity and promote tissue repair. Tissue antigens activate regulatory cells, which are
essential for preserving the homeostasis of the immune system. Mutations causing
impairments in these cells can lead to serious autoimmune disorders in humans and
animals, highlighting the critical role immune response regulation plays in maintaining general health (Nicholson 2016).
Table 12.1 Co-inhibitory molecules involved in the intrinsic shutdown mechanism of immune
response
Receptor
family Molecules
CD28 CTLA-4
PD1
TIM Tim-3 CD4+, CD8+ Galectin9 Kassu etal. (2010), Zhu etal.
CD226 TIGIT CD4+, CD8+ CD155, CD112,
CTLA-4 cytotoxic T-lymphocyte-associated protein 4, PD1 programmed cell death 1, TIGIT T-cell
immunoglobulin and ITIM domain
Receptorexpressing cell
during infection Ligands References
CD4+
CD4+, CD8+
CD80, CD86
PD-L1, PD-L2
CD113
Kaufmann etal. (2007), Kassu
etal. (2010)
(2005), Jones etal. (2008)
Kassu etal. (2010), Day etal.
(2006), Palmer etal. (2013),
Shimauchi etal. (2007), Yasuma
etal. (2016)
12 Immunoinformatics fortheDiagnosis andMonitoring ofAutoimmune Diseases
https://t.me/med1917
251
12.3 Immunoinformatics Fundamentals
The multidisciplinary topic of immunoinformatics combines immunology and bioinformatics to interpret and evaluate the intricate workings of the immune system.
Researchers can look at several facets of the immune response, from antigen–antibody interactions to the identication of immunogenic epitopes, by methodically
applying computational and informatics methods.
12.3.1 Computational Analysis ofImmune Receptors
andMolecules
Immunoinformatics allows the analysis of immune receptors, including the highly
diverse T-cell receptors (TCRs). TCRs are diverse due to recombination in their
respective gene segments, that is, V (variable), D (diversity), and J (joining). This
recombination causes diversity in hypervariable complementarity determining
region (CDR), which is essential in binding to specic antigens (Davis and Bjorkman
1988). The utilization of sequence alignment algorithms, such as BLAST and
FASTA, facilitates the identication of conserved and variable regions within TCR
and BCR (B-cell receptor) sequences, enabling researchers to understand their
structural diversity and functional implications.
The immune system’s distinctive ability to identify foreign targets (nonself)
without harming the host’s tissues (self) is primarily mediated by T cells. T cells
identify their targets through interactions between T-cell receptors (TCRs) and
peptide- major histocompatibility complex (pMHC) molecules displayed by antigenpresenting cells (APCs). In the thymus, a broad range of peptide-specic, MHCrestricted TCR repertoires is formed through somatic gene rearrangements. Each of
these repertoires is represented by an individual T-cell clone, which undergoes positive and negative selection processes in the thymus. During these processes, T cells
are conditioned to recognize self-MHC and to tolerate any self-peptides presented.
This results in the development of a naive T-cell repertoire that is self-MHC
restricted and equipped to identify foreign peptides encountered in the peripheral
tissues (Davis et al. 2007). The prediction of major histocompatibility complex
(MHC)-binding peptides, essential for antigen presentation, is a critical component
of immunoinformatics research. Tools like NetMHC (Andreatta and Nielsen 2016),
SYFPEITHI (Class I) (Rammensee et al. 1999), and NetMHCIIpan (Class II)
(Jensen etal. 2018) aid in the accurate prediction of peptide-MHC-binding afnities, thereby assisting in the designing of peptide-based vaccines and immunotherapies (Fig.12.2).
252
https://t.me/med1917
Fig. 12.2 T-cell development and selection (traditional method) and immunoinformatics-based
computational analysis of immune receptor assisting in the design of immunotherapies
S. Gangwar et al.
12.3.2 Epitope Prediction andVaccine Design
A key focus of immunoinformatics is the prediction and characterization of epitopes. Epitope prediction algorithms, such as ElliPro, leverage sequence and structural data for the prediction of antibody epitopes in protein antigens, facilitating the
rational design of vaccines (Ponomarenko etal. 2008).
Rappuoli led reverse vaccinology (RV) in the early 1990s, a genome-centred
technique for identifying feasible protein vaccine candidates against Group B
meningococcus (MB) (Rappuoli 2000). Finding antigens that mostly reside in the
extracellular or outer membrane areas and elicit a humoral antibody response was
the main goal at rst. This required a thorough examination of every open reading
frame obtained from the MB strain MC58 genome sequence in order to identify
proteins that were anticipated to be lipoproteins, secreted, or surface exposed.
The RV technique, which incorporates computerized analysis of pathogenic protein sequences as the rst phase of the process, has transformed vaccine development. This facilitates the process of choosing a subset of potential vaccine candidates
(PVCs), which are promising antigens.
Several computational tools have been developed to predict potential vaccine
candidates such as VaxiJen (Doytchinova and Flower 2007), Vaxign (He etal. 2010),
NERVE (New Enhanced Reverse Vaccinology Environment) (Vivona etal. 2006),
Bowman-Heinson (Bowman etal. 2011), and VacSol (Rizwan etal. 2017).
12 Immunoinformatics fortheDiagnosis andMonitoring ofAutoimmune Diseases
https://t.me/med1917
253
12.3.3 Immune Repertoire Analysis
andHigh-Throughput Sequencing
The most recent developments in high-throughput sequencing technology have
transformed the analysis of immune repertoires, enabling the comprehensive proling of T- and B-cell receptor repertoires at unprecedented depth and scale.
Immunoinformatics pipelines, such as TraCeR (Stubbington etal. 2016), V’DJer
software (Mose etal. 2016), and MiXCR (Bolotin et al. 2015), facilitate the processing and analysis of large-scale immune repertoire sequencing data, providing
insights into clonal diversity, somatic hypermutation, and immune response dynamics (Bolotin etal. 2017).
Deep learning (DL) and bioinformatics are being introduced into the eld of
immunology while TCR repertoire sequencing technology is progressing. This is
mostly due to the fact that a single person’s repertoire data typically consist of
numerous sequences. Machine learning (ML) is a useful technique for deriving signicant insights from large data sets. It is now essential for repertoire sequencing
analysis. Additionally, ML has made it easier to create a new repertoire of
sequencing- based applications, such as the production of tailored cancer vaccines
(also known as neoantigen vaccines) (Ott etal. 2017) and fresh approaches to diagnosing infections such as COVID-19 (Gittelman etal. 2022). Beyond their use in
medicine, machine-learning-based analysis techniques are advancing basic science
in the area. The application of machine learning (ML) to repertoire sequencing is
expanding quickly (Katayama etal. 2022).
12.4 Immunoinformatics inAutoimmune Disease Diagnosis
The complicated and diverse nature of autoimmune disorders makes diagnosing
these conditions extremely difcult. Conventional diagnostic techniques frequently
depend on the identication of autoantibodies and clinical signs, which does not offer
enough specicity and sensitivity to reliably classify diseases. By enabling the identication of disease-specic biomarkers and the development of cutting-edge diagnostic tools, immunoinformatics, i.e., an emerging interdisciplinary eld that
integrates immunology, bioinformatics, and computational biology, has the potential
to transform the diagnosis of autoimmune diseases. Researchers can look at several
aspects of the immune response, from antigen–antibody interactions to the identication of immunogenic epitopes, by applying computational and informatics methods.
12.4.1 Identication ofBiomarkers
The identication and validation of novel biomarkers for the diagnosis of autoimmune diseases are greatly aided by immunoinformatics. Researchers can uncover
potential biomolecular signatures linked with particular autoimmune disorders by
254
https://t.me/med1917
analysing high-dimensional omics data, such as transcriptomics, proteomics, and
genomes, using computational algorithms and data mining techniques. As an example, integrated analysis of gene expression proles and protein–protein interaction
networks in the context of rheumatoid arthritis (RA) has resulted in the identication of candidate biomarkers with high diagnostic and prognostic value (Song
etal. 2023).
In clinical practice, biomarkers are essential, and nding biomarkers can be sped
up by applying immunoinformatics to data about proteins and the immune system.
Previous investigations have identied autoantibodies as serum biomarkers for systemic lupus erythematosus (SLE) (Zhu etal. 2015; Huang etal. 2012); however, the
entire pattern information required for diagnosis is absent from the preliminary
evaluation tests. In order to solve this, a novel method was created that precisely
distinguishes SLE patients using the k-nearest neighbour (kNN) algorithm, allowing them to obtain timely and reliable diagnoses (Binder etal. 2005).
S. Gangwar et al.
12.4.2 Peptide Microarray-Based Diagnostics
Peptide microarray technology powered by immunoinformatics has become a viable method for multiplexed autoantibody detection against certain peptide epitopes
linked to autoimmune disorders. Researchers can nd autoantibody signatures that
differentiate between various autoimmune disorders by synthesizing vast libraries
of disease-relevant peptides and applying high-throughput screening techniques. In
the case of rheumatoid arthritis (RA), researchers analysed gene expression data
and identied several key genes associated with immune response and inammatory signalling pathways using microarray data sets. Notably, they highlighted the
diagnostic signicance of specic genes such as CCR5, CCL5, CXCL9, CXCL10,
CXCL13, PNOC, TLR8, and CD52in RA.The study also emphasized the critical
role of the chemokine system in mediating leukocyte migration and the potential
implications of genes like TLR8 and CD52in the immune response and inammation in RA. Overall, the researchers aimed to uncover potential biomarkers and
therapeutic targets to advance the treatment of RA (Ren etal. 2020).
12.4.3 Computational Model Integrating Immunoinformatics
withImaging Techniques
In the medical eld, radiomics includes the extraction of valuable information from
radiographic images such as CT (computed tomography), MR (magnetic resonance), and PET (positron emission tomography) scans, along with machinelearning- based quantication of lesion areas and important immunologic data
(Uribe etal. 2019). This procedure aids in disease diagnosis, categorization, and
grading (van Helden etal. 2018; Lambin etal. 2012). When it comes to predicting
12 Immunoinformatics fortheDiagnosis andMonitoring ofAutoimmune Diseases
https://t.me/med1917
treatment response, radiomic characteristics from PET imaging work better than
more conventional metrics like tumour diameter, volume, and metastases. By lowering picture noise and obtaining more precise radiation characteristics, deep learning
applied to PET image reconstruction and post-processing of traditionally recovered
images along with immunologic data can improve the quality of PET images.
However, the low occurrence of certain diseases leads to difculties in differentiating between affected and unaffected lesion areas in PET scans (Mayerhoefer
etal. 2020).
255
12.5 Immunoinformatics forDisease Monitoring
In several pathological situations, such as cancer, autoimmune disorders, and infectious diseases, disease monitoring is essential for evaluating the effectiveness of
treatment, the course of the disease, and the likelihood of reappearance. The multidisciplinary discipline of immunoinformatics, which combines computational biology, bioinformatics, and immunology, provides cutting-edge methods and
instruments for the methodical study and tracking of immune responses in both
health and illness.
Multiple sclerosis (MS) is a multifaceted condition shaped by the interactions of
environmental and genetic elements, leading to disruptions in immune function.
The prevailing theory regarding its pathogenesis suggests that T-lymphocytes,
which are auto-reactive and activated in the periphery, especially those displaying
Th1 and Th17 phenotypes, inltrate the central nervous system (CNS) by exploiting
a compromised blood–brain barrier (BBB) (Yadav etal. 2015). Once within the
brain, these auto-reactive immune cells recruit macrophages, microglia, and B lymphocytes to promote inammation, leading to the generation of reactive oxygen
species (ROS), reactive nitrogen species (RNS), and inammatory cytokines, which
cause trauma to tissues (Dendrou etal. 2015).
Immunomodulating or immunosuppressive therapies are the basis of MS treatment. Over the last two decades, a number of monoclonal antibodies and oral medications have changed the therapeutic landscape signicantly. Thirteen active
ingredients are present in the approximately 20 medications that have been licensed
for as therapeutic of multiple sclerosis (MS), as dimethyl fumarate, glatiramer acetate, and interferon 1 beta are marketed under different brand names.
The vision of early therapeutic intervention has gained popularity in the MS
community in recent years since there is mounting evidence that brain damage starts
as soon as the disease manifests and continues throughout the course of the illness,
even in clinically silent phases (Trapp etal. 1998; Filippi etal. 2004; Knier etal.
2016). Studies conducted over an extended period of time show that patients with
earlier treatment outcomes saw reduced rates of relapse, disability accumulation,
and loss of brain volume (Ziemssen etal. 2015). There are rst-line medications
with varying modes of action, but it is still difcult to predict individual reactions,
and no laboratory examination has been proven to be a good indicator of drug
256
https://t.me/med1917
responsiveness or treatment failure in multiple sclerosis. Consequently, there is a
continuous search for fresh and trustworthy instruments to inform therapy choices.
Although tailored techniques seem promising, their current deployment in clinical
practice is limited due to the large number of variables that need to be taken into
account (Pennisi etal. 2013). In order to tackle this issue, a number of computer
models have been put out to depict the dynamics of multiple sclerosis (MS), particularly the relapsing-remitting MS (RRMS) kind. These models are intended to provide customized simulations when particular medications are administered.
Researchers developed a simulation framework capable of predicting the dynamics of relapsing-remitting multiple sclerosis (MS) patients undergoing specic drug
treatments. The goal of the study was to use a mechanistic model to predict treatment outcomes for individual MS patients by performing a thorough investigation
of the immune system’s behaviour. A number of rst-line medications, such as teriunomide, ngolimod, and IFN-β1a, as well as several second-line medications,
such as natalizumab and ocrelizumab, were included in the drug analysis.
Customized simulations were made possible by the simulation framework, which
offered multiple ways to mimic an actual patient in a virtual environment. The simulation in a patient was able to replicate several immunological repertoires, which is
essential for all simulations involving the dynamics of the immune system
(Pappalardo etal. 2020).
S. Gangwar et al.
12.6 Case Studies andApplication
12.6.1 Immunoinformatics Association ofHuman
Coronaviruses andAutoimmunity
Researchers explained the importance of conserved epitopes found in many coronaviruses and how they could affect immune response modulation and possibly even
trigger autoimmunity (Mathew etal. 2022). After applying bioinformatics screening to 351 whole human coronavirus genome sequences, 108 conserved areas were
found. Out of them, 16 were B-cell immunogenic epitopes and 19 were T-cell
immunogenic epitopes that may have an association with autoimmunity and
cross-reactivity.
Interestingly, these epitopes were detected in structural and non-structural proteins of SARS-CoV-2in addition to the spike protein. The presence of B-cell epitopes across a range of viral proteins suggests a complex immune response to the
virus. Furthermore, the potential impact of pre-existing immunity to other viruses
on the immunological response to SARS-CoV-2 is intriguing. Some of the identied B-cell epitopes exhibit potential cross-reactivity with other viruses, such as
human herpesvirus 4 and H1N1. This cross-reactivity could play a role in shaping
the overall immune response and has implications for understanding the broader
dynamics of immunity to SARS-CoV-2.
Additionally, the study demonstrated the similarity between human proteins and
some of the discovered B-cell epitopes, raising the possibility that molecular
12 Immunoinformatics fortheDiagnosis andMonitoring ofAutoimmune Diseases
https://t.me/med1917
mimicry is a crucial factor in the autoimmune diseases observed in COVID-19
patients (Marino Gammazza etal. 2020). According to a number of studies, there
may be a cross-reactivity between SARS-CoV-2 and the sections of the human proteome. This suggests that SARS-CoV-2 may cause cross-reactivity with the host’s
self- antigens, which could result in a range of clinical symptoms and autoimmune
disorders (Venkatakrishnan etal. 2020; Kanduc 2020).
The analysis of T-cell-mediated immune response revealed that some of the conserved T-cell epitopes of SARS-CoV matched T-cell epitopes in response to other
viruses. This emphasizes that prior exposure to other viruses may inuence the
immune response to SARS-CoV-2 and that there may be cross-reactivity among
coronaviruses (Grifoni etal. 2020; Braun etal. 2020). Additionally, the research
demonstrated that a sizable percentage of the discovered SARS-CoV-2 peptides
bound to HLA class I molecules, possibly triggering CD8+ and CD4+ T-cell
responses (Anderson etal. 2021). This result suggested that COVID-19 and HLA
types linked to autoimmune disorders and hyper-inammatory states may be related.
Most of the conserved B- and T-cell epitopes were found within the functional
domains of the SARS-CoV-2 proteins, notably close to the spike protein’s receptorbinding region, according to additional structural analysis. This emphasizes how
these epitopes may cause protective antibodies to be produced, which could prevent
or cause an allosteric effect on ACE2 binding, so affecting the infectiousness of the
virus (Galeotti and Bayry 2020). The study’s authors stressed the need for more
research, especially experimental studies to evaluate functional antibodies and the
immunogenic effect invivo, even though the results they reported were based on
immunoinformatic predictions. The research contributed to the renement of
knowledge about SARS-CoV-2 pathophysiology and potential consequences by
illuminating the intricate relation between viral epitopes and the immune system.
257
12.6.2 Inferring Microorganisms Associated withRheumatoid
Arthritis (RA)
In order to understand how human-associated microorganisms may cause rheumatoid arthritis (RA) through a process known as molecular mimicry, a study has been
conducted using an immunoinformatics investigation (Repac etal. 2021). The ndings offer insight into a variety of species that may contribute to the initiation of the
disease process by activating autoreactive T cells specic to RA. Notably, the
research highlights the critical role of autoreactive T cells in the disease’s inception,
even while B cells contribute to RA pathogenesis in later stages (van Hamburg and
Tas 2018; Chemin etal. 2019; Rashid etal. 2017).
Numerous potential RA-triggering organisms were found in the study, including
commensal species, opportunistic pathogens, and well-known pathogens including
P. mirabilis (Rashid and Ebringer 2007) and M. tuberculosis (Lan and Wu 1992). It
implies that components of the human microbiome may play a direct role in the
pathophysiology of RA, maybe going beyond the scope of their traditional roles in
inammation. Remarkably, certain components of the gut and oral microbiota,
258
https://t.me/med1917
including B. fragilis and several strains of Prevotella, were found to be putative trig-
gers (Scher and Abramson 2011). This is consistent with recent research that associates RA with disturbed gut and oral microbiota. The investigation also brought to
light the signicant potential of fungi, which are frequently disregarded as possible
initiators of the onset of RA.A number of new fungal diseases were suggested by
the study as potential RA triggers because of their closer evolutionary relationship
with humans and their capacity for molecular mimicry since they share homologous
peptides with human proteins. The investigation found putative T-cell epitopes
across many viral groups, including the Marseillevirus group, indicating their
potential signicance in inducing autoimmune reactions, even though the results
were less clear-cut for viruses (Colson and Raoult 2010).
Strict ltering guidelines were used in the study to guarantee the validity of the
results, taking into account the 80% sequence identity cut-off and the lack of alignment gaps. Despite these drawbacks, the work provides insightful information about
the contribution of fungi to autoimmunity as well as the possible direct involvement
of bacterial commensals in the pathophysiology of RA.It also emphasizes the need
to identify strong autoantigens, which are essential to comprehend a range of autoimmune diseases (Repac etal. 2021).
S. Gangwar et al.
12.7 Future Directions andChallenges
Through computational models and informatics tools, immunoinformatics, a rapidly developing eld, plays a critical role in furthering research in the eld of immunology (Tong and Ren 2009). Numerous obstacles and diverse paths become
apparent as we investigate its present patterns and potential future developments.
12.7.1 Future Directions
Enhanced Epitope Prediction
Immunoinformatics will likely focus on rening epitope prediction methods by utilizing advancements in articial intelligence and machine learning. This could lead
to more accurate predictions of immunogenic epitopes (Alkaff etal. 2020).
Personalized Immunotherapy
Immunoinformatics may aid in the development of individualized immunotherapies, which adjust treatments to individuals’ immunological proles. This has the
potential to transform disease management and improve therapy results (Oli
etal. 2020).
Соседние файлы в папке Библиотека им академика М.И. Перельмана